Successful Desensitization with Ferric Carboxymaltose

Authors

  • Özlem Özdedeoğlu Department of Chest Diseases, Division of Allergy, University of Health Sciences, Ankara Atatürk Chest Diseases and Chest Surgery Training and Research Hospital, Ankara http://orcid.org/0000-0001-8421-9904
  • Kurtuluş Aksu Department of Chest Diseases, Division of Allergy, University of Health Sciences, Ankara Atatürk Chest Diseases and Chest Surgery Training and Research Hospital, Ankara http://orcid.org/0000-0001-6195-1158
  • Buket Akdoğan Department of Chest Diseases, Division of Allergy, University of Health Sciences, Ankara Atatürk Chest Diseases and Chest Surgery Training and Research Hospital, Ankara http://orcid.org/0000-0003-2919-6660
  • Hale Ateş Department of Chest Diseases, Division of Allergy, University of Health Sciences, Ankara Atatürk Chest Diseases and Chest Surgery Training and Research Hospital, Ankara http://orcid.org/0000-0001-8374-5814
  • Gözde Buhari Department of Chest Diseases, Division of Allergy, University of Health Sciences, Ankara Atatürk Chest Diseases and Chest Surgery Training and Research Hospital, Ankara http://orcid.org/0000-0002-0787-0370
  • İlkay Kalkan Department of Chest Diseases, Division of Allergy, University of Health Sciences, Ankara Atatürk Chest Diseases and Chest Surgery Training and Research Hospital, Ankara http://orcid.org/0000-0002-9788-1056
  • Seçkin Özgül Department of Internal Medicine, University of Health Sciences, Ankara Atatürk Chest Diseases and Chest Surgery Training and Research Hospital, Ankara http://orcid.org/0000-0003-2867-4157
  • Görkem Kaya Department of Internal Medicine, University of Health Sciences, Ankara Atatürk Chest Diseases and Chest Surgery Training and Research Hospital, Ankara http://orcid.org/0000-0002-0149-7018

Keywords:

Desensitization, ferric carboxymaltose, hypersensitivity, iron deficiency anemia

Abstract

Parenteral iron treatment is used especially in patients who need urgent treatment, have intolerance symptoms to oral iron therapy, and/ or where therapy with oral iron supplementation is insufficient. Allergic reactions can be observed with intravenous iron containing medicines and they should thus only be administered by trained staff with appropriate resuscitation facilities. The European Medicines Agency does not approve the use of intravenous iron-containing products in patients with previous hypersensitivity reactions to other parenteral iron products in its 2013 recommendations to manage the risk of allergic reactions to intravenous iron-containing medicines. However, it may be an option to administer intravenous iron therapy with desensitization in patients who need urgent treatment, who cannot be treated effectively with oral iron preparations, or display intolerance to these products. Here we present the first case of successful ferric carboxymaltose desensitization in a patient who had suffered a prior reaction with the same medicine.

Downloads

Download data is not yet available.

Downloads

Published

2020-04-17

How to Cite

1.
Özdedeoğlu Özlem, Aksu K, Akdoğan B, Ateş H, Buhari G, Kalkan İlkay, Özgül S, Kaya G. Successful Desensitization with Ferric Carboxymaltose. AAI [Internet]. 2020 Apr. 17 [cited 2022 Jan. 24];18(1):51-3. Available from: https://aai.org.tr/index.php/aai/article/view/460

Issue

Section

Case Reports